24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Dec 19, 2011
Trial Information
Current as of June 15, 2025
Withdrawn
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is able to comply with the study procedures
- • 18-80 years old
- • Subjects diagnosed with glaucoma, based on presence of repeatable visual field loss and/or glaucomatous optic neuropathy based on masked review of optic disc stereophotographs and under ocular hypotensive treatment, or diagnosed with ocular hypertension, with an IOP of \> 22 mmHg at the screening visit and under ocular hypotensive treatment.
- • Subject has consented to be in the trial
- • Visual acuity of 20/200 or better
- • Presence of cataract requiring phacoemulsification with lens exchange
- • Ability to understand the character and individual consequences of the study
- • For women of childbearing potential, adequate contraception
- Exclusion Criteria:
- * Subjects presenting with any of the following criteria will not be included in the trial:
- • Subjects with contraindications for wearing contact lenses
- • Severe dry eye syndrome
- • Keratoconus or other corneal abnormality
- • Conjunctival or intraocular inflammation
- • Eye surgery prior to and throughout the study.
- • Full frame metal glasses during SENSIMED Triggerfish® monitoring
- • Known hypersensitivity to silicone, plaster or ocular anesthesia (proparacaine)
- • Pregnancy and lactation
- • Simultaneous participation in other clinical studies
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Jolla, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials